Chemomab Therapeutics

Contributing Author

Recent Articles by Chemomab Therapeutics

Jun-30	Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live'25 CMMB GlobeNewswire
Jun-11	Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis CMMB GlobeNewswire
Jun-03	Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis CMMB GlobeNewswire
May-15	Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update CMMB GlobeNewswire
May-05	Chemomab Announces Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis in Distinguished Plenary Session at DDW 2025 CMMB GlobeNewswire